[HTML][HTML] Mesenchymal stromal cell therapy (REGENACIP®), a promising treatment option in chronic limb threatening ischemia – a narrative review
S Desai, D Sharma, R Srinivas, V Balaji… - Stem Cell Research & …, 2024 - Springer
Abstract Chronic Limb Threatening Ischemia (CLTI) is a challenging clinical problem
associated with high morbidity and mortality. Endovascular interventions have been the …
associated with high morbidity and mortality. Endovascular interventions have been the …
Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy: Consensus recommendation from the Chinese Medical Association …
K Wang, Y Wang, W Shi, K Shen, K Tao… - Diabetes/Metabolism …, 2024 - Wiley Online Library
Diabetic foot ulcer complicated with lower extremity vasculopathy is highly prevalent, slow
healing and have a poor prognosis. The final progression leads to amputation, or may even …
healing and have a poor prognosis. The final progression leads to amputation, or may even …
[HTML][HTML] Unraveling the differential mechanisms of revascularization promoted by MSCs & ECFCs from adipose tissue or umbilical cord in a murine model of critical …
M Rojas-Torres, L Beltrán-Camacho… - Journal of Biomedical …, 2024 - Springer
Background Critical limb-threatening ischemia (CLTI) constitutes the most severe
manifestation of peripheral artery disease, usually induced by atherosclerosis. CLTI patients …
manifestation of peripheral artery disease, usually induced by atherosclerosis. CLTI patients …
[HTML][HTML] Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs
S Kannan, S Gokul Krishna, PK Gupta… - Scientific Reports, 2024 - nature.com
Mesenchymal stromal cells (MSC) from adult bone marrow are the most commonly used
cells in clinical trials. MSCs from single donors are the preferred starting material but suffer …
cells in clinical trials. MSCs from single donors are the preferred starting material but suffer …
[HTML][HTML] Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
Globally, a leg is amputated approximately every 30 seconds, with an estimated 85 percent
of these amputations being attributed to complications arising from diabetic foot ulcers …
of these amputations being attributed to complications arising from diabetic foot ulcers …
Arterial Leg Ulcers in the Octogenarian
AL Fierro, M Abeshouse, T Lagziel… - Clinics in Geriatric …, 2024 - geriatric.theclinics.com
More than 200 million adults are affected by peripheral arterial disease (PAD) globally, and
its prevalence continues to increase in the geriatric population at an alarming rate, affecting …
its prevalence continues to increase in the geriatric population at an alarming rate, affecting …
Применение клеточных препаратов для лечения критической ишемии нижних конечностей у пациентов с сахарным диабетом: обзор литературы
ГС Чуган, АВ Люндуп… - Проблемы …, 2024 - probl-endojournals.ru
THE APPLICATION OF CELL PRODUCTS FOR THE TREATMENT OF CRITICAL LIMB ISCHEMIA
IN PATIENTS WITH DIABETES MELLITUS: A REVIEW OF TH Page 1 НАУЧНЫЙ ОБЗОР 4 …
IN PATIENTS WITH DIABETES MELLITUS: A REVIEW OF TH Page 1 НАУЧНЫЙ ОБЗОР 4 …
Pooling of Human Bone Marrow Mesenchymal Stromal Cells from different Donors demonstrate Distinctive Advantage than Single Donor MSCs
S Kannan, PK Gupta, UK Kolkundkar - 2024 - researchsquare.com
Mesenchymal stromal cells (MSC) from adult bone marrow is most commonly used cells in
clinical trials. MSCs from single donors are the preferred starting material but suffer from a …
clinical trials. MSCs from single donors are the preferred starting material but suffer from a …
Fitness and Immunoregulatory Functions of Human Mesenchymal Stromal Cells From Immunologically Privileged Versus Immunologically Active Tissues
TU Faircloth - 2024 - search.proquest.com
Abstract Mesenchymal Stem/Stromal Cells (MSCs) are non-hematopoietic,
immunomodulatory cells with therapeutic potential. MSCs have been extensively …
immunomodulatory cells with therapeutic potential. MSCs have been extensively …